Registered Kenya · PPB

FLUCONAZOLE TABLETS USP 150 MG

FLUCONAZOLE TABLETS USP

H2015/22099/380 FLUCONAZOLE TABLETS USP 150 MG GENERIC/BIOSIMILARS

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2015/22099/380
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
FLUCONAZOLE TABLETS USP
Dosage form
FLUCONAZOLE TABLETS USP 150 MG
Strength
-
Pack size
ALU/ALU STRIP OF 1 TABLETS; SUCH 1 STRIPS IN A CARTON ALONG WITH LEAFLET
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Sai Pharmaceuticals
Applicant / LTR
MACLEODS PHARMACEUTICALS LIMITED
Country of origin
FOREIGN
Manufacturer location
Whitefield Edge, Junction of James Gichuru Road and Olengurone Road Lavington Nairobi KE, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:28:51 · updated 2026-07-26 09:28:02

Drug Interactions

26
Check interactions

Severe (2)

Bosentan - increases exposure

Fluconazole is predicted to increase the exposure to endothelin receptor antagonists (bosentan). Avoid.

Severe Study

Endothelin Receptor Antagonists - increases exposure

Fluconazole is predicted to increase the exposure to endothelin receptor antagonists (bosentan). Avoid.

Severe Study

Moderate (11)

Antiepileptics - increases concentration

Fluconazole increases the concentration of antiepileptics (fosphenytoin, phenytoin). Monitor concentration and adjust dose.

Moderate Study

Atorvastatin - increases exposure

Fluconazole is predicted to increase the exposure to statins (atorvastatin, simvastatin). Monitor and adjust dose. Also see TABLE 1 p. 1517.

Moderate Anecdotal

Coumarins - increases anticoagulant effect

Fluconazole increases the anticoagulant effect of coumarins. Monitor INR and adjust dose.

Moderate Study

Fluconazole - decreases exposure

Rifampicin slightly decreases the exposure to antifungals, azoles (fluconazole). Adjust dose.

Moderate Study

Fosphenytoin - increases concentration

Fluconazole increases the concentration of antiepileptics (fosphenytoin, phenytoin). Monitor concentration and adjust dose.

Moderate Study

Unknown (13)

Abrocitinib - increases exposure

Fluconazole is predicted to increase the exposure to abrocitinib. Adjust abrocitinib dose, p. 1380.

Unknown Study

Antiarrhythmics - increases exposure

Fluconazole is predicted to increase the exposure to antiarrhythmics (dronedarone). Theoretical → Also see TABLE 9 p. 1519

Unknown Theoretical

Cannabidiol - increases exposure

Fluconazoleispredictedtoincreasetheexposureto cannabidiol.oTheoretical

Unknown Theoretical

Cilostazol - increases exposure

Fluconazole is predicted to increase the exposure to cilostazol. Adjust cilostazol dose, p. 253.

Unknown Theoretical

Clopidogrel - decreases efficacy

Fluconazoleispredictedtodecreasetheefficacyofclopidogrel. Avoid.rTheoretical

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.